Stocks and Investing
Stocks and Investing
Wed, March 4, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Peter Lawson Initiated (SNDX) at Buy and Held Target at $15 on, Mar 4th, 2020
Peter Lawson of Barclays, Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Buy and Held Target at $15 on, Mar 4th, 2020.
Peter has made no other calls on SNDX in the last 4 months.
There is 1 other peer that has a rating on SNDX. Out of the 1 peers that are also analyzing SNDX, 0 agree with Peter's Rating of Hold.
This is the rating of the analyst that currently disagrees with Peter
- Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $17 on, Monday, January 13th, 2020